These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2305508)

  • 1. Cosmetic orchiectomy for prostate cancer.
    Chiou RK
    Urol Clin North Am; 1990 Feb; 17(1):13-6. PubMed ID: 2305508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical studies of subcapsular orchiectomy with an intracapsular testicular prosthesis--improving the quality of life in patients with prostatic cancer].
    Sakamoto M; Ikeuchi T; Kai Y
    Gan No Rinsho; 1989 Sep; 35(10):1143-8. PubMed ID: 2506386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine treatment of prostate cancer.
    Tammela T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):287-95. PubMed ID: 15663992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slow zoledronic acid releasing testis prostheses in the treatment of prostate cancer patients with bone metastases.
    Serefoglu EC; Balbay MD
    Med Hypotheses; 2009 Sep; 73(3):387-8. PubMed ID: 19403241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cosmetic orchiectomy. Surgical technique that meets medical and psychologic needs of patients with advanced prostatic carcinoma.
    Chiou RK
    Urology; 1990 Jul; 36(1):91-2. PubMed ID: 2368237
    [No Abstract]   [Full Text] [Related]  

  • 6. Endocrine therapy for prostate cancer.
    Sagalowsky AI
    Spec Top Endocrinol Metab; 1985; 7():101-29. PubMed ID: 3914094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical castration for cancer of the prostate. A simplified technic].
    Vallancien G
    Ann Urol (Paris); 1988; 22(2):135-6. PubMed ID: 3289475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The patient's choice of androgen-deprivation therapy in locally advanced prostate cancer: bicalutamide, a gonadotrophin-releasing hormone analogue or orchidectomy.
    Nyman CR; Andersen JT; Lodding P; Sandin T; Varenhorst E
    BJU Int; 2005 Nov; 96(7):1014-8. PubMed ID: 16225519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Testicular intra-albugineous prosthesis in the treatment of prostatic cancer and testicular necrosis due to torsion].
    Serrate Aguilera RG; Rius Espina G; Gutierrez del Pozo R; Regué Aldosa R
    Actas Urol Esp; 1988; 12(2):140-2. PubMed ID: 3414421
    [No Abstract]   [Full Text] [Related]  

  • 10. Overview of current status of total androgen deprivation in metastasized prostate cancer.
    Debruyne FM; Witjes WP
    Eur Urol; 1993; 24 Suppl 2():67-71. PubMed ID: 8262129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone health in men receiving androgen deprivation therapy for prostate cancer.
    Eastham JA
    J Urol; 2007 Jan; 177(1):17-24. PubMed ID: 17161994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative approaches to the hormonal treatment of advanced prostate cancer.
    Trachtenberg J
    Eur Urol; 1997; 32 Suppl 3():78-80. PubMed ID: 9267790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916.
    Montgomery RB; Goldman B; Tangen CM; Hussain M; Petrylak DP; Page S; Klein EA; Crawford ED;
    J Urol; 2007 Nov; 178(5):1946-51; discussion 1951. PubMed ID: 17868721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal therapy of prostate cancer: current concepts and future prospects.
    Smith JA
    Clin Ther; 1988; 10(3):281-6. PubMed ID: 3078908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epididymal sparing bilateral simple orchiectomy with epididymoplasty: preservation of esthetics and body image.
    Issa MM; Lendvay TS; Bouet R; Young MR; Petros JA; Marshall FF
    J Urol; 2005 Sep; 174(3):893-7. PubMed ID: 16093982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The change in the dihydrotestosterone level in the prostate before and after androgen deprivation therapy in connection with prostate cancer aggressiveness using the Gleason score.
    Nishiyama T; Ikarashi T; Hashimoto Y; Wako K; Takahashi K
    J Urol; 2007 Oct; 178(4 Pt 1):1282-8; discussion 1288-9. PubMed ID: 17698092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance with hormonal treatment for prostate cancer.
    Kaisary AV
    Br J Hosp Med; 1996 Mar 20-Apr 2; 55(6):359-66. PubMed ID: 8696636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoporosis after orchiectomy for prostate cancer.
    Daniell HW
    J Urol; 1997 Feb; 157(2):439-44. PubMed ID: 8996327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy.
    Herr HW; O'Sullivan M
    J Urol; 2000 Jun; 163(6):1743-6. PubMed ID: 10799173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytology of metastatic prostate cancer following orchiectomy and antiandrogen therapy: a diagnostic challenge.
    Rapkiewicz A; Gorokhovsky R; Farcon E; Das K
    Diagn Cytopathol; 2008 Jul; 36(7):499-502. PubMed ID: 18528888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.